97699-68-8

Basic information

• Product Name: {[(6-methoxynaphthalen-2-yl)acetyl]oxy}acetic acid - methane (1:1)
• CAS NO: 97699-68-8
• Molecular Formula: C₁₆H₁₆O₅
• Molecular Weight: 290.3111
• Mol File: 97699-68-8.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 486°C at 760 mmHg
• Flash Point: 184.4°C
• Vapor Pressure: 2.93E-10mmHg at 25°C
• CAS DataBase Reference: {[(6-methoxynaphthalen-2-yl)acetyl]oxy}acetic acid - methane (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: {[(6-methoxynaphthalen-2-yl)acetyl]oxy}acetic acid - methane (1:1)(97699-68-8)
• EPA Substance Registry System: {[(6-methoxynaphthalen-2-yl)acetyl]oxy}acetic acid - methane (1:1)(97699-68-8)

Safety Data

• Hazardous Substances Data: 97699-68-8(Hazardous Substances Data)

Upstream product

• 97699-67-7 2-(6-methoxynaphthalen-2-yl)propionic acid benzyloxycarbonylmethyl ester 
• 22204-53-1 (2S)-2-(6-methoxy(2-naphthyl))propanoic acid 
• 646509-90-2 ((tert-butyl)oxycarbonyl)methyl (2S)-2-(6-methoxy(2-naphthyl))propanoate 
• 23981-80-8 naproxen 
• 79-14-1 glycolic Acid 
• 38835-18-6 naproxen chloride 

Downstream Products

• 886458-14-6 (N-cyclohexyl-N-(2-(nitrooxy)ethyl)carbamoyl)methyl (2S)-2-(6-methoxy(2-naphthyl))propanoate 

Relevant articles and documents

ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES

The present invention relates to the discovery of a new class of hydrolysable isocyanates, hydrolysable branched polyols and branched absorbable polyesters and polyurethanes prepared therefrom. The resultant absorbable polymers are useful for drug delivery, stents, highly porous foam, reticulated foam, tissue engineering, tissue adhesives, adhesion prevention, bone wax formulations, medical device coatings, surface modifying agents and other implantable medical devices. In addition, these absorbable polymers can have a controlled hydrolytic degradation profile.

Controlled Release of Nitric Oxide And Drugs From Functionalized Macromers And Oligomers

The present invention provides NO and, optionally, drug releasing macromers and oligomers wherein the drug molecule and NO releasing moiety are linked an absorbable macromer or oligomeric chain susceptible to hydrolytic degradation and wherein the macrome

CHEMICAL COMPOUNDS CONTAINING TOCOPHEROL AND AT LEAST ONE ADDITIONAL PHARMACEUTICAL ACTIVE SUBSTANCE

The invention relates to chemical compounds in the form of racemates, enantiomers and/or diastereomers of general formula (I), wherein R represents the non-modified part of a variable pharmaceutical active substance molecule, B represents a spacer and Toc and corresponds to formula (II), R′, R′′ and R′′′ are H or methyl for tocopherol and A is C=X, SOm, X and/or CH2. X is O, S or NR1 (n = 1) and/or S or NR1 (n = 0) and B is a group X-R 2 y, wherein Y is C=X, SOm or C (XR 3 ) R4, and n is 0 - 6, preferably 0,1, 2 or 3 and m represents 1 or 2. R1 represents H, C1 - C10 -alkyl, preferably C1 - C6-alkyl and/or aryl, Het or an aryl radical and/or a Het radical connected via a C1 - C6 spacer, preferably C1 - C3 and R2 is selected from the group containing alkene, arylene and/or Het spacer and combinations thereof and can be combined directly with each other or via the A radical and/or via the group XO-A-Xp, wherein o and p can be equal or different and are 0, 1 or 2, and R3 and R4 represent H, C1 - C10 alkyl, preferably C1-C6-alkyl and/or aryl, Het or an aryl radical and/or a Het radical bound by means of a C1 - C6, preferably C1 - C3 spacer.